Poxel S.A. (EPA:POXEL)
France
· Delayed Price · Currency is EUR 0.206
-0.001 (-0.48%)
Jun 26, 2026, 5:29 PM CET
Poxel Employees
Poxel had 5 employees as of June 30, 2025. The number of employees decreased by 1 or -16.67% since the number was reported on December 31, 2024.
Employees
5
Change
-1
Growth
-16.67%
Revenue / Employee
€1,531,400
Profits / Employee
€2,732,800
Market Cap
11.04M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| NFL Biosciences | 4 |
| Aton | 9 |
| Aelis Farma | 16 |
| Advicenne | 11 |
| Oncodesign Precision Medicine Société anonyme | 13 |
| GenSight Biologics | 13 |
| TME Pharma | 12 |
| Plant Advanced Technologies | 11 |
Poxel News
- 18 days ago - Poxel Appoints Yves Decadt as Chief Executive Officer to Accelerate Portfolio Development and Strategic Partnerships - Business Wire
- 5 weeks ago - Poxel Reports First Quarter 2026 Revenue and Provides a Business Update - Business Wire
- 5 weeks ago - Poxel Earnings release: Q1 2026 - Filings
- 2 months ago - Poxel: Postponement of the Publication of the 2025 Annual Financial Statements and the Annual Financial Report - Business Wire
- 3 months ago - Poxel To Sell PXL770 To Scynexis For Up To $196 Mln; Shares Up - Nasdaq
- 3 months ago - Poxel announces sale of PXL770 to Scynexis for up to $196M - TheFly
- 3 months ago - Poxel Confirms the Drawdown Under the Additional Tranche D PDR Bond Issue as Part of the Continuation Plan - Business Wire
- 4 months ago - Poxel Reports its 2025 Revenue and Provides an Update on its Financial Position - Business Wire